Drug intelligence / Profile preview

dexamethasone + l-5-hydroxytryptophan

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination of two agents: - **Dexamethasone** is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressant properties. It acts primarily by binding to the glucocorticoid receptor, modulating gene expression to suppress inflammation and immune responses. - **L-5-Hydroxytryptophan (L-5-HTP)** is an amino acid precursor to serotonin. It increases central nervous system serotonin synthesis by bypassing the rate-limiting step in tryptophan metabolism. When administered together, L-5-hydroxytryptophan can partially reverse or "escape" the suppression of hypothalamic-pituitary-adrenal (HPA) axis hormones (such as ACTH and cortisol) induced by dexamethasone in individuals with major depression. This effect appears related to serotonergic stimulation overcoming glucocorticoid negative feedback on pituitary hormone secretion[1][2][3]. The combination has been studied mainly for neuroendocrine research purposes rather than as a marketed therapeutic product.

Other names
dexamethasone and l-5-hydroxytryptophandexamethasone + 5-HTPdexamethasone + L-5-HTP
02

Targets

GR (Glucocorticoid receptor)DDC (Aromatic L-amino acid decarboxylase)HTR2A (Serotonin receptor 5-HT2A)

Beyond the preview

Go deeper on dexamethasone + l-5-hydroxytryptophan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + l-5-hydroxytryptophan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call